Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7501 p566
10 May 2008

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

• New professional body (2)
• Council election (2)
• Trimethoprim
• Restricted title
• Addiction
• Medicines use reviews
• English Pharmacy Board
• Epilepsy
• Euthanasia
• Public relations
• The Society


Letters to the Editor

Council election

He who pays the piper calls the tune (Mr N. Baumber)

Boots objective to be highly influential externally (A Boots Pharmacist)

He who pays the piper calls the tune

From Mr N. Baumber, FRPharmS

You reported (PJ, 3 May 2008, p528) that Tricia Kennerley, Boots’s healthcare director, encouraged Boots pharmacists to vote for the two Boots candidates standing in this year’s Royal Pharmaceutical Society elections to “help maintain the company’s key objective of being highly influential externally”. I see that Boots now chairs the National Pharmacy Association.

While her statement confirms my suspicions about the intended fate of the Society it completely undermines the reassurances offered by Steve Churton in his recent letter (PJ, 19 April 2008, p471).

He wrote: “I am sure my colleagues would agree with me when I say that we are grateful for the support that our employer affords us, which enables us to take an active part in supporting the profession and its future, but we are conscious that we were, or hope to be, elected by the membership, and as such are dedicated to serve in the best interests of the membership.” Is that so?

The nub of the issue is this: the new professional body that succeeds the Society may not be able to represent members’ interests if membership is voluntary and its survival is dependent on whether or not a large organisation is prepared to pay several thousand membership fees for its staff.

I am sure that those of us who want to support the Society into the future want it to represent pharmacists’ interests and not those of other organisations. This is of prime importance, not just at the outset in deciding the role of the new body, but also through the subsequent threat of withdrawal of funding which would be an ongoing anxiety contingent upon the “right” policies being adopted.

Moreover, a conflict of interest could arise between independence of mind and company policy. Would that result in abstentions, resignations or firm leadership by courtesy of Alliance Boots?

The Society elections are over for this year but we should have known where each candidate stood on such issues as the following:

• Technicians having full membership of the future professional body (as recommended by the Clarke report)

• Remote supervision of a pharmacy (where the pharmacist is not present)

• Plans for pharmacies to be run for up to three hours with no pharmacist on the premises

• Whether or not companies should be allowed to subscribe on behalf of their members of staff allowing them to claim a political interest, or even to seek a volume discount

Noel Baumber
Grantham, Lincolnshire


Boots objective to be highly influential externally

From A Boots Pharmacist

I do not know whether Peter Walker has ever pondered upon the fact that not all Boots pharmacists are members of the Boots Pharmacists’ Association (PJ, 26 April 2008, p506). Perhaps I, as an employee pharmacist of Boots UK, can offer some insight.

Mr Walker asks where is the evidence that Boots employees have used their commercial connections with Boots to influence the profession unduly? I do not have any evidence to offer, but I have read the statement posted by Tricia Kennerley (healthcare director, Boots UK) on Boots MyStoreNet on 25 April 2008.

In it, she states: “Two of our colleagues at Boots UK are standing for election to positions at the Royal Pharmaceutical Society. By voting for them you could help maintain the company’s key objective of being highly influential externally.” Ms Kennerley then goes on to “urge” us all to give them both “our support” and “vote for Jonathan”.

My reason for not being a member of the Boots Pharmacists’ Association is that I have long held the belief that the relationship with Boots is too cosy. Here is yet another example of a senior member of the Boots Pharmacists’ Association either exhibiting a degree of naivety that ill becomes someone purporting to represent the interests of Boots employee pharmacists or someone who is unwilling to face up to the facts that Boots UK has a strategic objective of being highly influential externally and that the company believes that this can be maintained by electing its employees to positions on the Society’s Council and the English Pharmacy Board.

A Boots Pharmacist
298/6

Send your letter to The Editor

Previous Topic (New professional body)
Next Topic (Trimethoprim)

Back to Top


©The Pharmaceutical Journal